JP7196320B2 - グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法 - Google Patents

グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法 Download PDF

Info

Publication number
JP7196320B2
JP7196320B2 JP2021543440A JP2021543440A JP7196320B2 JP 7196320 B2 JP7196320 B2 JP 7196320B2 JP 2021543440 A JP2021543440 A JP 2021543440A JP 2021543440 A JP2021543440 A JP 2021543440A JP 7196320 B2 JP7196320 B2 JP 7196320B2
Authority
JP
Japan
Prior art keywords
active region
ethanol
glucose
membrane
responsive active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021543440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518923A (ja
Inventor
オーヤン、ティエンメイ
ジェイ． フェルドマン、ベンジャミン
チョ、ヒョン
エヌ． トラン、ラム
オージャ、スティーブン
ケイ． スローン、マーク
クマール、アシュウィン
キアイエ、ナムバー
アール． ラブ、マイケル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Publication of JP2022518923A publication Critical patent/JP2022518923A/ja
Priority to JP2022199250A priority Critical patent/JP7524288B2/ja
Application granted granted Critical
Publication of JP7196320B2 publication Critical patent/JP7196320B2/ja
Priority to JP2024113856A priority patent/JP2024137994A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/18—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state for vehicle drivers or machine operators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4845—Toxicology, e.g. by detection of alcohol, drug or toxic products
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
    • B60K28/00—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions
    • B60K28/02—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver
    • B60K28/06—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
    • B60K28/00—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions
    • B60K28/02—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver
    • B60K28/06—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver
    • B60K28/063—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver preventing starting of vehicles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60K—ARRANGEMENT OR MOUNTING OF PROPULSION UNITS OR OF TRANSMISSIONS IN VEHICLES; ARRANGEMENT OR MOUNTING OF PLURAL DIVERSE PRIME-MOVERS IN VEHICLES; AUXILIARY DRIVES FOR VEHICLES; INSTRUMENTATION OR DASHBOARDS FOR VEHICLES; ARRANGEMENTS IN CONNECTION WITH COOLING, AIR INTAKE, GAS EXHAUST OR FUEL SUPPLY OF PROPULSION UNITS IN VEHICLES
    • B60K28/00—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions
    • B60K28/02—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver
    • B60K28/06—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver
    • B60K28/066—Safety devices for propulsion-unit control, specially adapted for, or arranged in, vehicles, e.g. preventing fuel supply or ignition in the event of potentially dangerous conditions responsive to conditions relating to the driver responsive to incapacity of driver actuating a signalling device
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/98—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving alcohol, e.g. ethanol in breath
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
    • B60W40/00—Estimation or calculation of non-directly measurable driving parameters for road vehicle drive control systems not related to the control of a particular sub unit, e.g. by using mathematical models
    • B60W40/08—Estimation or calculation of non-directly measurable driving parameters for road vehicle drive control systems not related to the control of a particular sub unit, e.g. by using mathematical models related to drivers or passengers
    • B60W2040/0818—Inactivity or incapacity of driver
    • B60W2040/0836—Inactivity or incapacity of driver due to alcohol
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60W—CONJOINT CONTROL OF VEHICLE SUB-UNITS OF DIFFERENT TYPE OR DIFFERENT FUNCTION; CONTROL SYSTEMS SPECIALLY ADAPTED FOR HYBRID VEHICLES; ROAD VEHICLE DRIVE CONTROL SYSTEMS FOR PURPOSES NOT RELATED TO THE CONTROL OF A PARTICULAR SUB-UNIT
    • B60W2540/00—Input parameters relating to occupants
    • B60W2540/24—Drug level, e.g. alcohol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mechanical Engineering (AREA)
  • Transportation (AREA)
  • Combustion & Propulsion (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
JP2021543440A 2019-01-28 2020-01-28 グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法 Active JP7196320B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022199250A JP7524288B2 (ja) 2019-01-28 2022-12-14 グルコース及びエタノールのデュアル検出のための分析物センサ
JP2024113856A JP2024137994A (ja) 2019-01-28 2024-07-17 グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962797566P 2019-01-28 2019-01-28
US62/797,566 2019-01-28
US201962884841P 2019-08-09 2019-08-09
US62/884,841 2019-08-09
PCT/US2020/015400 WO2020159981A1 (en) 2019-01-28 2020-01-28 Analyte sensors and sensing methods for dual detection of glucose and ethanol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022199250A Division JP7524288B2 (ja) 2019-01-28 2022-12-14 グルコース及びエタノールのデュアル検出のための分析物センサ

Publications (2)

Publication Number Publication Date
JP2022518923A JP2022518923A (ja) 2022-03-17
JP7196320B2 true JP7196320B2 (ja) 2022-12-26

Family

ID=69724151

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021543440A Active JP7196320B2 (ja) 2019-01-28 2020-01-28 グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法
JP2022199250A Active JP7524288B2 (ja) 2019-01-28 2022-12-14 グルコース及びエタノールのデュアル検出のための分析物センサ
JP2024113856A Pending JP2024137994A (ja) 2019-01-28 2024-07-17 グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022199250A Active JP7524288B2 (ja) 2019-01-28 2022-12-14 グルコース及びエタノールのデュアル検出のための分析物センサ
JP2024113856A Pending JP2024137994A (ja) 2019-01-28 2024-07-17 グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法

Country Status (9)

Country Link
US (2) US12220235B2 (enExample)
EP (2) EP4552565A1 (enExample)
JP (3) JP7196320B2 (enExample)
CN (2) CN113453620B (enExample)
AU (3) AU2020216330B2 (enExample)
CA (1) CA3126706A1 (enExample)
ES (1) ES2999412T3 (enExample)
LT (1) LT3917393T (enExample)
WO (1) WO2020159981A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3423591B1 (en) 2016-03-04 2023-11-01 Abbott Diabetes Care Inc. Nad(p)-dependent responsive enzymes, electrodes and sensors, and methods for making and using the same
WO2020159981A1 (en) * 2019-01-28 2020-08-06 Abbott Diabetes Care Inc. Analyte sensors and sensing methods for dual detection of glucose and ethanol
FI3917394T3 (fi) 2019-01-28 2024-11-12 Abbott Diabetes Care Inc Analyyttiantureita, joissa käytetään useita entsyymejä
AU2020419193B2 (en) 2020-01-03 2024-07-04 Abbott Diabetes Care Inc. Sensor array systems and methods for detecting multiple analytes
WO2021163378A1 (en) * 2020-02-11 2021-08-19 Life Patch International Devices, methods and systems related to wearable patch having blood alcohol content detector
CA3182587A1 (en) 2020-07-08 2022-01-13 Stephen OJA Analyte sensors featuring enhancements for decreasing interferent signal
WO2022051889A1 (zh) * 2020-09-08 2022-03-17 三诺生物传感股份有限公司 提高电化学活性的氧化还原酶及含有该氧化还原酶的生物传感器
WO2022109008A1 (en) * 2020-11-18 2022-05-27 Cercacor Laboratories, Inc. Glucose sensors and methods of manufacturing
AU2021400588B2 (en) * 2020-12-15 2025-04-10 Abbott Diabetes Care Inc. Nad(p) depot for nad(p)-dependent enzyme-based sensors
CN116634940A (zh) * 2020-12-18 2023-08-22 美国雅培糖尿病护理公司 用于分析物检测的系统和方法
CN116897014A (zh) * 2020-12-23 2023-10-17 美国雅培糖尿病护理公司 连续型钾传感器及其使用方法
WO2022139876A1 (en) * 2020-12-23 2022-06-30 Abbott Diabetes Care Inc. Analyte sensors with reduced interferent signal and methods
US12097760B2 (en) * 2021-07-28 2024-09-24 Caterpillar Inc. Methods and systems for detecting a machine operator
AU2024205934A1 (en) 2022-12-30 2025-04-17 Abbott Diabetes Care Inc. Drug delivery compositions and methods of controlling drug delivery rates of subcutaneous sensors
AU2024211188A1 (en) 2023-01-25 2025-07-17 Abbott Diabetes Care Inc. Temperature-insensitive membranes for analyte sensors
WO2024243577A1 (en) 2023-05-24 2024-11-28 Abbott Diabetes Care Inc. Methods for incorporating therapeutic agents into analyte sensors
CN116735885B (zh) * 2023-05-25 2025-02-11 深圳硅基传感科技有限公司 多分析物监测传感器

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120132525A1 (en) 1999-11-15 2012-05-31 Abbott Diabetes Care Inc. Redox polymers for use in analyte monitoring
US20130131478A1 (en) 2003-07-25 2013-05-23 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264105A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5792621A (en) * 1995-06-28 1998-08-11 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Fiber-optic chemiluminescent biosensors for monitoring aqueous alcohols and other water quality parameters
JP2900876B2 (ja) * 1996-03-19 1999-06-02 サンケン電気株式会社 表示装置の電源装置
US5696314A (en) 1996-07-12 1997-12-09 Chiron Diagnostics Corporation Multilayer enzyme electrode membranes and methods of making same
EP0921198B1 (en) * 1997-04-24 2006-07-19 ARKRAY, Inc Method for enzymatically assaying saccharification protein
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6030827A (en) 1998-01-23 2000-02-29 I-Stat Corporation Microfabricated aperture-based sensor
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6241863B1 (en) 1998-04-27 2001-06-05 Harold G. Monbouquette Amperometric biosensors based on redox enzymes
US8268143B2 (en) 1999-11-15 2012-09-18 Abbott Diabetes Care Inc. Oxygen-effect free analyte sensor
EP1230249B1 (en) 1999-11-15 2004-06-02 Therasense, Inc. Transition metal complexes with bidentate ligand having an imidazole ring
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6875613B2 (en) * 2001-06-12 2005-04-05 Lifescan, Inc. Biological fluid constituent sampling and measurement devices and methods
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
CA2521304A1 (en) * 2003-04-04 2004-10-21 Lumidigm, Inc. Multispectral biometric sensor
US7460898B2 (en) 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP1685258A4 (en) 2003-10-29 2007-08-29 Agency Science Tech & Res BIOSENSOR
WO2005048834A1 (en) 2003-11-13 2005-06-02 Medtronic Minimed, Inc. Long term analyte sensor array
EP2256493B1 (en) 2003-12-05 2014-02-26 DexCom, Inc. Calibration techniques for a continuous analyte sensor
JP4802842B2 (ja) 2006-04-24 2011-10-26 株式会社デンソー 健康管理支援装置及び健康管理システム
US7831287B2 (en) * 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8808515B2 (en) 2007-01-31 2014-08-19 Abbott Diabetes Care Inc. Heterocyclic nitrogen containing polymers coated analyte monitoring device and methods of use
WO2008157820A1 (en) 2007-06-21 2008-12-24 Abbott Diabetes Care, Inc. Health management devices and methods
CA2984510C (en) 2007-09-24 2020-06-09 Ascensia Diabetes Care Holdings Ag Multi-region and potential test sensors, methods, and systems
CA2715624A1 (en) 2008-02-20 2009-08-27 Dexcom, Inc. Continuous medicament sensor system for in vivo use
US8620398B2 (en) 2008-06-02 2013-12-31 Abbott Diabetes Care Inc. Reference electrodes having an extended lifetime for use in long term amperometric sensors
EP2163190A1 (de) * 2008-09-11 2010-03-17 Roche Diagnostics GmbH Elektrodensystem für Messung einer Analytkonzentration in-vivo
US8608922B2 (en) * 2008-11-07 2013-12-17 The University Of Connecticut Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof
EP4252639A3 (en) 2009-02-26 2024-01-03 Abbott Diabetes Care Inc. Method of calibrating an analyte sensor
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
US8721870B2 (en) * 2009-03-19 2014-05-13 Edwards Lifesciences Corporation Membrane system with sufficient buffering capacity
EP3001194B1 (en) 2009-08-31 2019-04-17 Abbott Diabetes Care, Inc. Medical devices and methods
WO2011030093A1 (en) 2009-09-04 2011-03-17 Lifescan Scotland Limited Glucose measurement method and system
US20120181189A1 (en) 2009-09-24 2012-07-19 Fresenius Medical Care Holdings, Inc. Amperometric Creatinine Biosensor With Immobilized Enzyme-Polymer Composition And Systems Using Same, And Methods
US8545693B2 (en) 2009-09-29 2013-10-01 Lifescan Scotland Limited Analyte measurment method and system
US20120283537A1 (en) 2009-10-30 2012-11-08 Petisce James R Analyte sensor layers and methods related thereto
US9402574B2 (en) 2010-06-25 2016-08-02 The University Of Connecticut Sensors for analyte detection and methods of manufacture thereof
US20130211219A1 (en) 2010-08-24 2013-08-15 Micro CHIPS ,Inc. Implantable Biosensor Device and Methods of Use Thereof
US9468402B2 (en) * 2010-12-01 2016-10-18 Pinnacle Technology, Inc. Tissue implantable microbiosensor
EP4397242A3 (en) 2010-12-09 2024-08-28 Abbott Diabetes Care Inc. Analyte sensors with a sensing surface having small sensing spots
US8608921B2 (en) 2011-01-20 2013-12-17 Medtronic Minimed, Inc. Layered enzyme compositions for use with analyte sensors
US20140054171A1 (en) * 2012-02-21 2014-02-27 Abbott Diabetes Care Inc. Analyte Sensor Utilizing Oxygen as Oxidant
WO2013165318A1 (en) * 2012-05-03 2013-11-07 National University Of Singapore A mediator-less electrochemical glucose sensing procedure employing the leach-proof covalent binding of an enzyme(s) to electrodes and products thereof
US9788765B2 (en) * 2012-09-28 2017-10-17 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US8921061B2 (en) 2012-11-02 2014-12-30 Roche Diagnostics Operations, Inc. Reagent materials and associated test elements
US9344777B2 (en) 2012-12-20 2016-05-17 Abbott Diabetes Care Inc. Wireless communication authentication for medical monitoring device
US10426383B2 (en) * 2013-01-22 2019-10-01 Medtronic Minimed, Inc. Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating
US9487811B2 (en) 2013-03-15 2016-11-08 Abbott Point Of Care Inc. Biosensor structures for improved point of care testing and methods of manufacture thereof
US9562874B2 (en) 2013-03-15 2017-02-07 Abbott Point Of Care Inc. Biosensor with improved interference characteristics
US9544313B2 (en) 2013-12-27 2017-01-10 Abbott Diabetes Care Inc. Systems, devices, and methods for authentication in an analyte monitoring environment
EP3797686B1 (en) * 2014-10-22 2024-12-25 DexCom, Inc. User interfaces for continuous glucose monitoring
JP6584821B2 (ja) * 2015-04-30 2019-10-02 株式会社東芝 測定用セル、検出装置および分析装置
US10238346B2 (en) * 2015-09-25 2019-03-26 Sanmina Corporation System and method for a biosensor integrated in a vehicle
US10228341B2 (en) * 2015-10-15 2019-03-12 Arkray, Inc. Biosensor
US10324058B2 (en) * 2016-04-28 2019-06-18 Medtronic Minimed, Inc. In-situ chemistry stack for continuous glucose sensors
WO2018079465A1 (ja) 2016-10-24 2018-05-03 パナソニックヘルスケアホールディングス株式会社 電子メディエータの酸化剤
CA3065339A1 (en) 2017-06-30 2019-01-03 Abbott Diabetes Care Inc. Method and apparatus for analyte detection using an electrochemical biosensor
DE202018006591U1 (de) 2017-08-18 2021-07-21 Abbott Diabetes Care, Inc. Systeme und Vorrichtungen betreffend die individualisierte Kalibrierung und/oder Herstellung von medizinischen Vorrichtungen
DE102018209611A1 (de) * 2018-06-14 2019-12-19 RUHR-UNIVERSITäT BOCHUM Verfahren zur Entfernung von gelöstem Sauerstoff bei einem elektrochemischen Biosensor, der als Sensorenzym eine Oxidase verwendet
US11744492B2 (en) 2018-08-29 2023-09-05 Medtronic, Inc. Electrochemical sensor including multiple work electrodes and common reference electrode
FI3917396T3 (fi) 2019-01-28 2024-11-29 Abbott Diabetes Care Inc Analyyttiantureita, joilla voidaan havaita sekä glukoosia että ketoneita
CN119454012A (zh) 2019-01-28 2025-02-18 美国雅培糖尿病护理公司 检测肌酐的分析物传感器和感测方法
FI3917394T3 (fi) 2019-01-28 2024-11-12 Abbott Diabetes Care Inc Analyyttiantureita, joissa käytetään useita entsyymejä
WO2020159981A1 (en) * 2019-01-28 2020-08-06 Abbott Diabetes Care Inc. Analyte sensors and sensing methods for dual detection of glucose and ethanol
WO2020194179A1 (en) 2019-03-24 2020-10-01 Baldwa Mehul Biosensor for detection of analytes in a fluid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120132525A1 (en) 1999-11-15 2012-05-31 Abbott Diabetes Care Inc. Redox polymers for use in analyte monitoring
US20130131478A1 (en) 2003-07-25 2013-05-23 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise

Also Published As

Publication number Publication date
US20250221643A1 (en) 2025-07-10
JP2024137994A (ja) 2024-10-07
LT3917393T (lt) 2024-12-27
CA3126706A1 (en) 2020-08-06
CN113453620A (zh) 2021-09-28
EP4552565A1 (en) 2025-05-14
EP3917393A1 (en) 2021-12-08
WO2020159981A1 (en) 2020-08-06
JP2023027272A (ja) 2023-03-01
US20200237277A1 (en) 2020-07-30
AU2020216330A1 (en) 2021-08-12
AU2020216330B2 (en) 2023-04-13
JP2022518923A (ja) 2022-03-17
CN113453620B (zh) 2024-03-05
JP7524288B2 (ja) 2024-07-29
AU2025223845A1 (en) 2025-09-18
AU2023204567B2 (en) 2025-06-05
US12220235B2 (en) 2025-02-11
ES2999412T3 (en) 2025-02-25
EP3917393B1 (en) 2024-09-18
AU2023204567A1 (en) 2023-08-03
CN118105070A (zh) 2024-05-31

Similar Documents

Publication Publication Date Title
JP7196320B2 (ja) グルコース及びエタノールのデュアル検出のための分析物センサ及び検知方法
JP7634121B2 (ja) グルコースとケトンの二重検出を特徴とする分析対象物センサー及び検出方法
JP7669463B2 (ja) 複数の酵素を用いた分析物センサ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210827

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220809

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221102

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221214

R150 Certificate of patent or registration of utility model

Ref document number: 7196320

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150